Overview
Researchers at Forescout Technologies disclosed 20 newly identified vulnerabilities affecting serial-to-IP converter devices manufactured by Lantronix and Silex Technology. These devices are widely deployed in operational technology (OT) environments and healthcare settings to connect legacy serial equipment — such as medical instruments, infusion pumps, and laboratory analyzers — to modern IP networks.
The vulnerabilities include flaws that could allow unauthenticated remote access, credential exposure, and arbitrary command execution. Forescout researchers also described theoretical attack scenarios demonstrating how an adversary could chain multiple weaknesses to move laterally through a network or disrupt connected medical equipment.
Patches and mitigations have been issued by the affected vendors, but the disclosure highlights a persistent blind spot in healthcare network security: the large installed base of legacy connectivity hardware that bridges older medical devices to networked infrastructure, often without adequate monitoring or update cycles.
## Key developments
Twenty vulnerabilities across two vendors. Forescout identified the flaws in Lantronix and Silex serial-to-IP converter product lines. The severity and specific CVE designations were detailed in the researchers' published findings, with several vulnerabilities rated at high or critical levels based on their potential for unauthenticated exploitation.
Attack scenarios target medical and OT environments. The researchers outlined theoretical scenarios in which an attacker with network access could exploit these converters to intercept serial communications, extract stored credentials, or execute commands on the device — potentially affecting downstream connected equipment such as diagnostic instruments.
Legacy bridging hardware lacks consistent security lifecycle management. Serial-to-IP converters are frequently deployed and then left unmanaged for years. Unlike endpoint computers, they rarely appear in standard vulnerability management scans, and firmware update practices for these devices remain inconsistent across healthcare organizations.
Vendor patches are available but deployment is the challenge. Both Lantronix and Silex have responded with fixes, but healthcare organizations must first identify all such devices on their networks — a step that requires active network discovery — before remediation can begin.
## Industry impact
The disclosure fits a documented pattern of risk in healthcare OT and medical device security. The HHS Health Sector Cybersecurity Coordination Center (HC3) has repeatedly flagged legacy connectivity hardware as an underaddressed attack surface in healthcare environments. The FDA's 2023 final guidance on cybersecurity in medical devices acknowledged the risk of networked legacy equipment but applies prospectively to new device submissions, leaving existing installed bases subject to organizational policy rather than regulatory mandate.
The IBM Cost of a Data Breach Report has consistently ranked healthcare as the sector with the highest average breach cost — $10.93 million in the 2023 report — with network-connected devices representing one factor in the complexity of healthcare breach investigations. Serial-to-IP converters that touch patient data flows, such as those connected to laboratory or monitoring equipment, may fall within the scope of HIPAA's technical safeguard requirements under 45 C.F.R. § 164.312, which requires covered entities to implement controls that limit access to ePHI-bearing systems and audit activity on those systems.
## What this means for independent practices
- Conduct a full network device inventory. Standard IT asset management tools often miss embedded hardware such as serial converters, terminal servers, and similar devices. Network scanning with protocols capable of identifying these devices is a necessary first step before any remediation can occur.
- Check whether Lantronix or Silex devices are present. Any practice using legacy laboratory analyzers, infusion pump management systems, or older diagnostic equipment connected to an IP network should verify whether serial-to-IP converters are part of that infrastructure. - Apply available firmware updates promptly. Both affected vendors have issued patches. Once devices are identified, administrators should confirm firmware versions against vendor advisories and apply updates according to each vendor's guidance.
- Segment legacy device networks. Serial converters and the equipment they connect should reside on isolated network segments with strictly limited access from clinical workstations, administrative systems, and internet-facing infrastructure. - Include embedded hardware in risk analysis. HIPAA's required risk analysis under 45 C.F.R. § 164.308(a)(1) must account for all systems that create, receive, maintain, or transmit ePHI. Devices that relay data from medical instruments to networked systems fall within that scope.
For independent practices, the standing implication is that network security discipline must extend beyond computers and servers to include the full range of connectivity hardware — devices that were often installed by equipment vendors, may predate current IT staff, and rarely receive routine security review. Establishing a process to identify, document, and monitor these devices is a compliance requirement, not an optional improvement.
What would have prevented this
Network asset discovery with embedded device coverage: Active network scanning tools configured to identify non-standard device classes — including serial servers, terminal servers, and OT connectivity hardware — would allow organizations to know these devices exist before a vulnerability disclosure forces the question.
Firmware lifecycle management: A defined process for tracking vendor firmware advisories for all networked hardware, including non-PC devices, and a tested procedure for applying updates, would reduce the window of exposure when vulnerabilities in devices like these are disclosed.
Network segmentation: Placing legacy serial-connected equipment on isolated network segments with firewall rules that restrict inbound and outbound traffic to only the specific hosts and ports required would limit an attacker's ability to use a compromised converter as a pivot point into broader clinical or administrative systems.
Privileged access monitoring: Monitoring and logging authentication attempts and configuration changes on network-connected devices — including embedded hardware — provides the visibility needed to detect credential-based exploitation attempts before they escalate.
Vendor security advisory monitoring: Subscribing to security advisories from all hardware vendors whose equipment is deployed — and assigning responsibility for reviewing those advisories — ensures that disclosures like this one translate into timely internal action rather than deferred awareness.